BeInCrypto·
Moderna Slides Up to 25% as Cancer Vaccine Meets Sky-High Expectations
-25%
Moderna share drop
Moderna fell up to 25% despite a cancer vaccine that cut melanoma recurrence or death risk 42%, as expectations ran high.
More news
- TokenPostBroadcom Shares Trade Near $326 as $320 Support Comes Into View
- TokenPostJupiter Adds Token Swaps to Decrypt Media’s Reading Platform
- TokenPostBitcoin Long Liquidations Hit $12.55 Million in One Hour
- TokenPostLegora’s Daily Active Users Spend More Than Two Hours on Its Platform
- TokenPostCommodity Markets Council Urges CFTC to Block Kalshi's WTI Perpetuals
- TokenPostTrump Faces Lawsuit Over Alleged Profits From UAE Crypto Deals